No abstract available
Keywords:
Epigenetic modification; Platinum resistance; Relapsed small cell lung cancer.
Publication types
-
Clinical Trial, Phase II
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Azacitidine / therapeutic use
-
Carboplatin / therapeutic use
-
Humans
-
Lung Neoplasms* / drug therapy
-
Small Cell Lung Carcinoma* / drug therapy
Substances
-
Carboplatin
-
guadecitabine
-
Azacitidine